✦ LIBER ✦

Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis.

✍ Scribed by Ilona Ujfalussy; Éva Koó; Magdolna Seszták; Péter Gergely

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of disease-modifying antirheumatic d

✍ Laurent Marguerie; René-Marc Flipo; Bruno Grardel; Didier Beaurain; Bernard Duqu 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Conventional disease-modifying antirheum

✍ T. Rath; O. Sander; A. Rubbert 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Prediction of response to disease modify

✍ Jean-Francis Maillefert; Xavier Puéchal; Géraldine Falgarone; Gérard Lizard; Pau 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 225 KB

Cost effectiveness analysis of disease m

✍ Manathip Osiri; Pirom Kamolratanakul; Andreas Maetzel; Peter Tugwell 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 242 KB

The early use of disease-modifying antir

✍ Edward S. Mongan 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Conventional Disease-Modifying Antirheum

✍ Sokka, Tuulikki; Hannonen, Pekka; Möttönen, Timo 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 277 KB